CUNNINGHAM SHARON C ET AL: "AAV2/8-mediated correction of OTC deficiency is robust in adult but not neonatal Spf(ash) mice.", MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY AUG 2009, vol. 17, no. 8, August 2009 (2009-08), pages 1340-1346, XP55191785, ISSN: 1525-0024 cited in the application (B1)

JAMES M WILSON ET AL: "Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency", 25 October 2011 (2011-10-25), MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, AMSTERDAM, NL, PAGE(S) 263 - 265, XP028447658, ISSN: 1096-7192 [retrieved on 2011-11-07] the whole document (B1)

L WANG ET AL: "Sustained correction of OTC deficiency in spf?ash mice using optimized self-complementary AAV2/8 vectors", GENE THERAPY, vol. 19, no. 4, 18 August 2011 (2011-08-18), pages 404-410, XP055190744, ISSN: 0969-7128, DOI: 10.1038/gt.2011.111 cited in the application (B1)

LI ZHONG ET AL: "Recombinant Adeno-Associated Virus Integration Sites in Murine Liver After Ornithine Transcarbamylase Gene Correction", HUMAN GENE THERAPY, vol. 24, no. 5, 1 May 2013 (2013-05-01), pages 520-525, XP055191501, ISSN: 1043-0342, DOI: 10.1089/hum.2012.112 (B1)

LILI WANG ET AL: "137: Neonatal Gene Therapy for OTC Deficiency", MOLECULAR THERAPY, vol. 20, no. Suppl. 1, 1 May 2012 (2012-05-01), - 19 May 2012 (2012-05-19), page S56, XP055190918, GB ISSN: 1525-0016, DOI: 10.1038/mt.2012.86 (B1)

LILI WANG ET AL: "Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, AMSTERDAM, NL, vol. 105, no. 2, 31 October 2011 (2011-10-31), pages 203-211, XP028447650, ISSN: 1096-7192, DOI: 10.1016/J.YMGME.2011.10.020 [retrieved on 2011-11-07] cited in the application (B1)

YAPLITO-LEE JOY ET AL: "Histopathological findings in livers of patients with urea cycle disorders", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, AMSTERDAM, NL, vol. 108, no. 3, 23 January 2013 (2013-01-23), pages 161-165, XP028980879, ISSN: 1096-7192, DOI: 10.1016/J.YMGME.2013.01.006 (B1)

M SPADA ET AL: "161-P: Novel OTC gene deletion and somatic mosaicism in a boy with late onset OTC deficiency and early liver cirrhosis.", JOURNAL OF INHERITED METABOLIC DISEASE., vol. 26, no. Suppl. 2, 1 September 2003 (2003-09-01), - 6 September 2003 (2003-09-06), page 81, XP055192267, NL ISSN: 0141-8955, DOI: 10.1023/A:1024858629434 (B1)

MOSCIONI ET AL: "Long-Term Correction of Ammonia Metabolism and Prolonged Survival in Ornithine Transcarbamylase-Deficient Mice Following Liver-Directed Treatment with Adeno-associated Viral Vectors", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 14, no. 1, 1 July 2006 (2006-07-01), pages 25-33, XP005560368, ISSN: 1525-0016 cited in the application (B1)

SANAE NUMATA ET AL: "Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients", JOURNAL OF HUMAN GENETICS, SPRINGER-VERLAG, TO, vol. 53, no. 1, 20 November 2007 (2007-11-20), pages 10-17, XP019565993, ISSN: 1435-232X (B1)

SAORI YAMAGUCHI ET AL: "Mutations and polymorphisms in the human ornithine transcarbamylase ( OTC ) gene", HUMAN MUTATION, vol. 27, no. 7, 1 July 2006 (2006-07-01), pages 626-632, XP055192171, ISSN: 1059-7794, DOI: 10.1002/humu.20339 (B1)

VOTHKNECHT UTE C ET AL: "Protein import: The hitchhikers guide into chloroplasts", BIOLOGICAL CHEMISTRY, vol. 381, no. 9-10, September 2000 (2000-09), pages 887-897, ISSN: 1431-6730 (B1)

WO-A2-2013/151666 (B1)

LILI WANG ET AL: "Systematic Evaluation of AAV Vectors for Liver directed Gene Transfer in Murine Models", MOLECULAR THERAPY, vol. 18, no. 1, 27 October 2009 (2009-10-27), pages 118-125, XP055022848, ISSN: 1525-0016, DOI: 10.1038/mt.2009.246 (B1)